Literature DB >> 2728515

Effect of auxiliary prescription labels on the elderly ambulatory patient's drug knowledge.

B M Gryfe-Becker1, H J Segal, T R Einarson.   

Abstract

The elderly take more drugs per capita than younger age groups. As a result, they may require more drug information. Auxiliary prescription labels are a common, yet little studied method of providing drug information. We studied 4 groups of 20 patients aged 65 or older, who obtain prescriptions at community pharmacies. They received either auxiliary label(s), counseling, both counseling and auxiliary labels, or no supplementary information at all. Counseling provided the same information verbally as was provided on the labels. Patients were interviewed 3-15 days later. Sixty-six percent were able to read auxiliary labels without difficulty. Significantly more patients who received auxiliary labels, with counseling (65 percent) or without counseling (63 percent), were able to recall supplementary information correctly and completely compared with patients who did not receive supplementary information (25 percent). However, a significant improvement in understanding or ability to apply this information was not found. Counseling alone did not significantly improve either outcome. It was concluded that the use of auxiliary labels is a useful, although not ideal, method of providing drug information for elderly patients in a busy community pharmacy setting.

Entities:  

Mesh:

Year:  1989        PMID: 2728515     DOI: 10.1177/106002808902300409

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  2 in total

Review 1.  Labelling deficiencies and communication problems leading to medication misuse in the elderly.

Authors:  B A Kroner; C L Kelley; E M Baranowski
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

2.  Quantifying age-related differences in information processing behaviors when viewing prescription drug labels.

Authors:  Raghav Prashant Sundar; Mark W Becker; Nora M Bello; Laura Bix
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.